Dnca Finance Has $2.58 Million Stock Holdings in Danaher Corporation $DHR

Dnca Finance decreased its position in shares of Danaher Corporation (NYSE:DHRFree Report) by 75.0% during the 3rd quarter, Holdings Channel reports. The fund owned 13,000 shares of the conglomerate’s stock after selling 39,000 shares during the quarter. Dnca Finance’s holdings in Danaher were worth $2,577,000 at the end of the most recent quarter.

Other large investors have also recently bought and sold shares of the company. WFA of San Diego LLC acquired a new stake in Danaher during the 2nd quarter worth $26,000. ANTIPODES PARTNERS Ltd bought a new stake in shares of Danaher in the third quarter worth about $27,000. Howard Hughes Medical Institute bought a new stake in shares of Danaher in the second quarter worth about $27,000. TruNorth Capital Management LLC acquired a new stake in shares of Danaher during the third quarter worth about $28,000. Finally, Tripletail Wealth Management LLC acquired a new stake in shares of Danaher during the third quarter worth about $31,000. Institutional investors own 79.05% of the company’s stock.

Insiders Place Their Bets

In other news, EVP Gregory M. Milosevich sold 1,320 shares of Danaher stock in a transaction on Thursday, February 19th. The stock was sold at an average price of $208.01, for a total transaction of $274,573.20. Following the completion of the sale, the executive vice president owned 5,099 shares of the company’s stock, valued at approximately $1,060,642.99. This trade represents a 20.56% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 11.10% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

Several equities analysts recently issued reports on DHR shares. Morgan Stanley began coverage on Danaher in a research report on Monday, December 1st. They issued an “overweight” rating and a $270.00 price objective for the company. The Goldman Sachs Group dropped their target price on shares of Danaher from $270.00 to $265.00 and set a “buy” rating on the stock in a report on Thursday, January 29th. Robert W. Baird set a $251.00 price target on shares of Danaher in a research note on Thursday, January 29th. Wells Fargo & Company upped their price target on shares of Danaher from $230.00 to $240.00 and gave the company an “equal weight” rating in a report on Monday, December 15th. Finally, Leerink Partners raised their price objective on shares of Danaher from $260.00 to $270.00 and gave the stock an “outperform” rating in a report on Friday, January 16th. Nineteen analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, Danaher currently has an average rating of “Moderate Buy” and a consensus target price of $253.55.

View Our Latest Stock Analysis on Danaher

Danaher Trading Up 0.6%

Shares of DHR stock opened at $187.34 on Friday. Danaher Corporation has a 12-month low of $171.00 and a 12-month high of $242.80. The company has a market capitalization of $132.47 billion, a PE ratio of 37.17, a price-to-earnings-growth ratio of 2.52 and a beta of 0.93. The firm has a 50 day moving average price of $218.79 and a two-hundred day moving average price of $215.34. The company has a quick ratio of 1.51, a current ratio of 1.87 and a debt-to-equity ratio of 0.35.

Danaher (NYSE:DHRGet Free Report) last announced its earnings results on Tuesday, January 27th. The conglomerate reported $2.23 earnings per share for the quarter, topping analysts’ consensus estimates of $2.14 by $0.09. The company had revenue of $6.84 billion for the quarter, compared to analyst estimates of $6.79 billion. Danaher had a return on equity of 10.81% and a net margin of 14.71%.The firm’s quarterly revenue was up 4.6% compared to the same quarter last year. During the same quarter last year, the company earned $2.14 earnings per share. As a group, analysts predict that Danaher Corporation will post 7.63 earnings per share for the current year.

Danaher Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 24th. Shareholders of record on Friday, March 27th will be given a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a yield of 0.9%. The ex-dividend date is Friday, March 27th. This is a positive change from Danaher’s previous quarterly dividend of $0.32. Danaher’s dividend payout ratio (DPR) is 25.40%.

About Danaher

(Free Report)

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

Featured Stories

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHRFree Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.